Treace Medical Concepts Inc (NAS:TMCI)
$ 5.94 0.08 (1.37%) Market Cap: 368.33 Mil Enterprise Value: 324.10 Mil PE Ratio: 0 PB Ratio: 2.91 GF Score: 41/100

Q4 2021 Treace Medical Concepts Inc Earnings Call Transcript

Mar 03, 2022 / 09:30PM GMT
Release Date Price: $20.41 (-1.31%)
Operator

Good day, and thank you for standing by. Welcome to the Treace Medical Concepts Fourth Quarter and Full Year 2021 Earnings Conference Call. (Operator Instructions)

Now it is my pleasure to hand the conference over to your host today, Vivian Cervantes with Gilmartin, Investor Relations. Please go ahead.

Vivian Cervantes;Gilmartin;Managing Director
Investor Relations,

Thank you, Paul. Good afternoon, everyone, and welcome to our fourth quarter and full year 2021 earnings conference call. Participating from the company today will be John Treace, Chief Executive Officer; and Mark Hair, Chief Financial Officer.

During the call, we will offer commentary on our commercial activity and review our fourth quarter and full year financial results released after the close of the market today, after which we will host a question-and-answer session. The press release can be found in the Investor Relations section of our website at investors.treace.com. This call is being recorded and will be archived in the Investors

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot